- Home
- PRQR vs OSUR Comparison
PRQR vs OSUR Comparison
Compare PRQR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | OSUR |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.5M | 254.5M |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PRQR | OSUR |
|---|---|---|
| Price | $1.63 | $3.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.22 | N/A |
| AVG Volume (30 Days) | ★ 511.7K | 497.0K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $9.20 | $6.16 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $2.08 |
| 52 Week High | $3.10 | $4.58 |
Technical Indicators
Market Signals| Indicator | PRQR | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 31.81 | 59.54 |
| Support Level | $1.64 | $3.89 |
| Resistance Level | $1.99 | $3.93 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 10.00 | 78.33 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.